Sign in

CIK 0000879169

  • Large accelerated filer

INCYTE CORP

Sign in to watch
Ticker
INCY
Exchange
Nasdaq
Industry
Services-Commercial Physical & Biological Research
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943136539
Phone
+1 302-498-6700
Business address
1801 AUGUSTINE CUT-OFF, WILMINGTON, DE, 19803
Former names
INCYTE INC, INCYTE GENOMICS INC, INCYTE PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,285,604
in 7 filings, $33.3M under 10b5-1 plans

Net −$33,285,604. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-11-16 Stein Steven H CMO & Head of Late-Stage Dev. Exercise or conversion 10b5-1 +576 $68.25 $39K 31,492
2026-11-16 Stein Steven H CMO & Head of Late-Stage Dev. Sale 10b5-1 −576 $121.98 $70K 30,916
2026-11-16 Stein Steven H CMO & Head of Late-Stage Dev. Exercise or conversion · Employee Stock Option (right to buy) 10b5-1 −576 20,146
2026-11-16 CAGNONI PABLO J President, Global Head of R&D Exercise or conversion 10b5-1 +455 $61.18 $28K 183,655
2026-11-16 CAGNONI PABLO J President, Global Head of R&D Exercise or conversion 10b5-1 +422 $61.76 $26K 184,077
2026-11-16 CAGNONI PABLO J President, Global Head of R&D Exercise or conversion 10b5-1 +926 $64.25 $59K 185,003
2026-11-16 CAGNONI PABLO J President, Global Head of R&D Exercise or conversion 10b5-1 +839 $71.93 $60K 185,842
2026-11-16 CAGNONI PABLO J President, Global Head of R&D Sale 10b5-1 −877 $121.98 $107K 184,965
2026-11-16 CAGNONI PABLO J President, Global Head of R&D Sale 10b5-1 −1,765 $120.46 $213K 183,200
2026-11-16 CAGNONI PABLO J President, Global Head of R&D Exercise or conversion · Employee Stock Option (right to buy) 10b5-1 −455 3,641
2026-11-16 CAGNONI PABLO J President, Global Head of R&D Exercise or conversion · Employee Stock Option (right to buy) 10b5-1 −422 3,380
2026-11-16 CAGNONI PABLO J President, Global Head of R&D Exercise or conversion · Employee Stock Option (right to buy) 10b5-1 −926 18,505
2026-11-16 CAGNONI PABLO J President, Global Head of R&D Exercise or conversion · Employee Stock Option (right to buy) 10b5-1 −839 16,788
2026-11-13 Heeson Lee EVP, Head of Incyte Intl Sale 10b5-1 −1,471 $121.89 $179K 36,107
2026-11-13 Heeson Lee EVP, Head of Incyte Intl Sale 10b5-1 −2,200 $120.44 $265K 33,907
2026-11-13 Heeson Lee EVP, Head of Incyte Intl Sale 10b5-1 −874 $121.16 $106K 33,033
2026-11-13 Heeson Lee EVP, Head of Incyte Intl Sale 10b5-1 −3,700 $120.33 $445K 29,333
2026-11-13 Heeson Lee EVP, Head of Incyte Intl Sale 10b5-1 −2,449 $121.13 $297K 26,884
2026-11-06 Stein Steven H CMO & Head of Late-Stage Dev. Exercise or conversion 10b5-1 +8,539 $68.62 $586K 39,455
2026-11-06 Stein Steven H CMO & Head of Late-Stage Dev. Exercise or conversion 10b5-1 +12,335 $72.27 $891K 51,790

Page 1 of 35 · 681 trades